
Accepting New Patients
Nathaniel Robinson, MD
Lung/Thoracic Cancer|
Medical Oncology
Speaks:Â EnglishÂ
Care Provided
Specialties
Locations
Neag Comprehensive Cancer Center
UConn Health
Outpatient Pavilion, 4th Floor
263 Farmington Avenue
Farmington, CT 06030
GPS: 135 Dowling Way, Farmington, CT
860-679-2100Education & Training
Education
BA, Harvard College, Medicine - 2010
MD, Yale School of Medicine, Medicine - 2017
Internship
Internal Medicine, Hospital of the University of Pennsylvania - 2019
Residency
Internal Medicine, Hospital of the University of Pennsylvania - 2019
Internal Medicine, University of California, San Francisco - 2020
Fellowship
Hematology-Oncology (Clinical), Yale School of Medicine/Smilow Cancer Hospital - 2024
Board Certification
Internal Medicine
Clinical Trials
- A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084 in Combination With Subcutaneous Pembrolizumab and Berahyaluronidase alfa (MK-3475A) Versus MK-3475A in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Chemotherapy as First-line Treatment of Participants With KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous NSCLC (KANDLELIT-007)
- A Phase III, Randomized, Double-Blind, Multicenter; Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients with PD-L1-high Metastatic Non-small cell Lung Cancer (ARTEMIDE-Lung04)
